Jeff Boyle | Senior Director, IR |
Jeffrey Jonas | CEO |
Michael Cloonan | Chief Business Officer |
Kimi Iguchi | CFO |
Steve Kanes | Chief Medical Officer |
Jim Doherty | Chief Research Officer |
Akash Tewari | Wolfe Research |
Paul Matteis | Stifel |
Tazeen Ahmad | Bank of America |
Salveen Richter | Goldman Sachs |
Andrew Tsai | Jefferies |
Yatin Suneja | Guggenheim Partners |
Thomas Lavery | Morgan Stanley |
Neena Bitritto-Garg | Citi |
Cory Kasimov | JPMorgan |
Jay Olson | Oppenheimer |
Ladies and gentlemen, thank you for standing by, and welcome to the SAGE Therapeutics Second Quarter 2020 Financial Results Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Jeff Boyle, Senior Director of Investor Relations. Thank you. Please go ahead, sir.